DE602005018972D1 - 5,6-dimethylthienoä2,3-diüpyrimidinderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzung für die bekämpfung von viren - Google Patents

5,6-dimethylthienoä2,3-diüpyrimidinderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzung für die bekämpfung von viren

Info

Publication number
DE602005018972D1
DE602005018972D1 DE602005018972T DE602005018972T DE602005018972D1 DE 602005018972 D1 DE602005018972 D1 DE 602005018972D1 DE 602005018972 T DE602005018972 T DE 602005018972T DE 602005018972 T DE602005018972 T DE 602005018972T DE 602005018972 D1 DE602005018972 D1 DE 602005018972D1
Authority
DE
Germany
Prior art keywords
pharmaceutical composition
hepatitis
dietyrimidin
derivatives
production
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602005018972T
Other languages
English (en)
Inventor
Cheol Kyu Han
Jeonghyeok Yoon
Nam-Doo Kim
Jin-Ah Kim
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Equispharm Co Ltd
Original Assignee
Equispharm Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Equispharm Co Ltd filed Critical Equispharm Co Ltd
Publication of DE602005018972D1 publication Critical patent/DE602005018972D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
DE602005018972T 2005-09-23 2005-09-23 5,6-dimethylthienoä2,3-diüpyrimidinderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzung für die bekämpfung von viren Active DE602005018972D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/KR2005/003172 WO2007035010A2 (en) 2005-09-23 2005-09-23 5,6-dimethylthieno[2,3-di] pyrimidine derivatives, the preparation method thereof and the pharmaceutical composition comprising the same for anti-virus

Publications (1)

Publication Number Publication Date
DE602005018972D1 true DE602005018972D1 (de) 2010-03-04

Family

ID=37889268

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005018972T Active DE602005018972D1 (de) 2005-09-23 2005-09-23 5,6-dimethylthienoä2,3-diüpyrimidinderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzung für die bekämpfung von viren

Country Status (8)

Country Link
US (1) US7816351B2 (de)
EP (1) EP1928884B1 (de)
JP (1) JP4767321B2 (de)
CN (1) CN101268081B (de)
AT (1) ATE455117T1 (de)
AU (1) AU2005336552B2 (de)
DE (1) DE602005018972D1 (de)
WO (1) WO2007035010A2 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007081517A2 (en) * 2005-12-21 2007-07-19 Abbott Laboratories Anti-viral compounds
CN101384592A (zh) * 2005-12-21 2009-03-11 艾博特公司 抗病毒化合物
AU2006330924B2 (en) 2005-12-21 2012-03-15 Abbvie Inc. Anti-viral compounds
DE602006015861D1 (de) 2005-12-21 2010-09-09 Abbott Lab Antivirale verbindungen
US8236950B2 (en) 2006-12-20 2012-08-07 Abbott Laboratories Anti-viral compounds
HUE035589T2 (en) 2010-05-26 2018-05-28 Korea Inst Sci & Tech An anti-inflammatory compound having an anti-tyrosine kinase inhibitory activity and a pharmaceutical composition containing it
AR090037A1 (es) * 2011-11-15 2014-10-15 Xention Ltd Derivados de tieno y/o furo-pirimidinas y piridinas inhibidores de los canales de potasio
WO2015057945A1 (en) 2013-10-18 2015-04-23 Indiana University Research And Technology Corporation Hepatitis b viral assembly effectors
CN107922377A (zh) 2015-04-17 2018-04-17 美国印第安纳大学研究和技术公司 乙肝病毒组装效应子
SG11201804901WA (en) 2015-12-22 2018-07-30 SHY Therapeutics LLC Compounds for the treatment of cancer and inflammatory disease
EA201992780A1 (ru) 2017-06-21 2020-06-02 ШАЙ ТЕРАПЬЮТИКС ЭлЭлСи Соединения, которые взаимодействуют с суперсемейством ras, для лечения рака, воспалительных заболеваний, ras-опатий и фиброзного заболевания

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1570494A (en) * 1975-11-28 1980-07-02 Ici Ltd Thienopyrimidine derivatives and their use as pesticides
FI824314L (fi) 1981-12-16 1983-06-17 Sankyo Co Thienopyrimidin-derivater, deras framstaellning och deras medicinska anvaendning
JPS58225089A (ja) * 1982-06-25 1983-12-27 Sankyo Co Ltd チエノピリミジン誘導体およびその製造法
DE69825558D1 (de) 1998-03-31 2004-09-16 St Microelectronics Srl Generator von Pulsen mit programmierbarer Dauer
US6133271A (en) * 1998-11-19 2000-10-17 Cell Pathways, Inc. Method for inhibiting neoplastic cells and related conditions by exposure thienopyrimidine derivatives
BRPI0408284B8 (pt) * 2003-03-12 2021-05-25 Kudos Pharm Ltd compostos derivados de ftalazinona, seu uso e composição farmacêutica compreendendo os mesmos
DE10351436A1 (de) 2003-11-04 2005-06-09 Merck Patent Gmbh Verwendung von Thienopyrimidinen

Also Published As

Publication number Publication date
CN101268081A (zh) 2008-09-17
EP1928884A4 (de) 2008-11-12
ATE455117T1 (de) 2010-01-15
AU2005336552A1 (en) 2007-03-29
EP1928884A2 (de) 2008-06-11
US20080234482A1 (en) 2008-09-25
WO2007035010A3 (en) 2007-05-24
AU2005336552B2 (en) 2010-09-16
JP2009508939A (ja) 2009-03-05
WO2007035010A2 (en) 2007-03-29
EP1928884B1 (de) 2010-01-13
CN101268081B (zh) 2010-12-29
US7816351B2 (en) 2010-10-19
JP4767321B2 (ja) 2011-09-07

Similar Documents

Publication Publication Date Title
DE602005018972D1 (de) 5,6-dimethylthienoä2,3-diüpyrimidinderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzung für die bekämpfung von viren
WO2006046030A3 (en) Tetracyclic indole derivatives as antiviral agents
WO2007029029A3 (en) Tetracyclic indole derivatives as antiviral agents
EP2041159B8 (de) Makrozyklische verbindungen als antivirale mittel
WO2006027628A3 (en) Naphthalimide derivatives as antiviral agents
WO2005084192A3 (en) Novel 2’-c-methyl nucleoside derivatives
WO2007112028A3 (en) 2'-fluoronucleoside phosphonates as antiviral agents
MY128463A (en) 4' substituted nucleosides for the treatment of diseases mediated by the hepatitis c virus
WO2008021928A3 (en) Hepatitis c virus inhibitors
PL366726A1 (en) 4'-substituted nucleosides for the treatment of diseases mediated by the hepatitis c virus
SG149067A1 (en) IMIDAZO[4,5-c]PYRIDINE COMPOUNDS AND METHODS OF ANTIVIRAL TREATMENT
WO2004113365A3 (en) Hepatitis c serine protease tri-peptide inhibitors
EP2341065A3 (de) Inhibitoren der Serinproteasen, insbesondere der Hepatitis-C-Virus-NS3-NS4A-Protease
DE602004023924D1 (en) Ease-hemmer
CA2445744A1 (en) Antiviral nucleoside derivatives
ATE383360T1 (de) 5-amino-2,4,7-trioxo-3,4,7,8-tetrahydro-2h- pyrido(2,3-d)pyrimidinderivate und verwandte verbindungen zur behandlung von krebs
NZ610715A (en) Antiviral compounds and methods
MXPA06000418A (es) Derivados de ariltiourea sustituida utiles como inhibidores de duplicacion viral.
ATE372995T1 (de) Benzo(b)(1,4)dioxepinderivate
TW200626567A (en) Benzoxazine and quinoxaline derivatives and uses
MXPA05010957A (es) Derivados de ornitina activos farmaceuticamente, sales de amonio de los mismos y metodos para su preparacion.
DE60315685D1 (de) 6-methylpyridinderivat, verfahren zu seiner herstellung und es enthaltende antivirale pharmazeutische zusammensetzung
CA2534558A1 (en) Ammonium salts of ornithine derivatives for treating inflammatory diseases
TH61095B (th) อนุพันธ์อะไซคลิกนิวคลีโอไซด์ฟอสฟอเนตชนิดใหม่ , เกลือของสารเหล่านี้ และกระบวนการสำหรับการเตรียมสารเดียวกัน
TH50555A (th) อนุพันธ์อิมิดาโซไพริดินที่เป็นตัวยับยั้งฟอสฟอไดเอสเทอเรส vii

Legal Events

Date Code Title Description
8364 No opposition during term of opposition